Strontium ranelate is a medicine with evidenced effects on the risk of fractures. The heterogeneity of strontium distribution in bone, quality of bone mineral crystals in young bone packets on bone surfaces formed during strontium ranelate administration, and activation of the calcium sensing receptor may, at least partially, explain the beneficial effects of SrR on reducing the risk of fractures. In this review, the concept of the dual action of strontium ranelate is also discussed. However, sufficient evidence for the bone anabolic effect of SrR does not exist in humans. The knowledge of the mechanism of action of SrR is important not only for the explanation of the effects of SrR upon the skeleton, but also for the safety of treatment for other tissues.

Institute of Rheumatology and 1st Faculty of Medicine Charles University Na Slupi 4 128 50 Prague 2 Czech Republic

Zobrazit více v PubMed

J Clin Endocrinol Metab. 2007 Aug;92(8):3076-81 PubMed

J Bone Miner Res. 2013 Jan;28(1):150-61 PubMed

Bone. 2013 Mar;53(1):51-8 PubMed

J Clin Endocrinol Metab. 2013 Feb;98(2):592-601 PubMed

Bone. 2009 Jan;44(1):113-9 PubMed

Presse Med. 2011 Oct;40(10):e453-62 PubMed

Osteoporos Int. 2010 Dec;21(12):2027-36 PubMed

J Bone Miner Res. 1993 May;8(5):607-15 PubMed

Bone. 2013 Mar;53(1):112-9 PubMed

Bone. 2011 May 1;48(5):972-8 PubMed

J Clin Endocrinol Metab. 2006 Mar;91(3):870-7 PubMed

J Bone Miner Res. 2010 Apr;25(4):891-900 PubMed

Osteoporos Int. 2012 Mar;23(3):1115-22 PubMed

J Clin Densitom. 1999 Winter;2(4):371-9 PubMed

Bone. 2010 Mar;46(3):571-6 PubMed

Osteoporos Int. 2013 Feb;24(2):567-80 PubMed

Bone. 2010 Apr;46(4):1038-42 PubMed

J Bone Miner Res. 2004 Dec;19(12):2012-20 PubMed

Osteoporos Int. 2009 Apr;20(4):653-64 PubMed

N Engl J Med. 2004 Jan 29;350(5):459-68 PubMed

J Bone Miner Res. 2007 Sep;22(9):1419-25 PubMed

Osteoporos Int. 2003;14 Suppl 3:S25-34 PubMed

J Bone Miner Res. 1996 Sep;11(9):1302-11 PubMed

J Bone Miner Res. 2008 Jan;23(1):6-16 PubMed

Osteoporos Int. 2011 Sep;22(9):2529-37 PubMed

Annu Rev Physiol. 2012;74:271-97 PubMed

Clin Chem Lab Med. 2011 Aug;49(8):1271-4 PubMed

Osteoporos Int. 2011 Jun;22(6):1659-67 PubMed

Bone. 2008 Mar;42(3):476-82 PubMed

J Clin Endocrinol Metab. 2005 May;90(5):2816-22 PubMed

Osteoporos Int. 2012 Jan;23(1):305-15 PubMed

Bone. 2008 Jan;42(1):129-38 PubMed

Clin Endocrinol (Oxf). 2009 Apr;70(4):522-6 PubMed

Mol Pharmacol. 2010 Oct;78(4):569-76 PubMed

Curr Med Res Opin. 2005 Feb;21(2):185-94 PubMed

J Bone Miner Res. 2008 Feb;23(2):215-22 PubMed

Calcif Tissue Int. 2013 Oct;93(4):299-306 PubMed

J Biol Chem. 2009 Jan 2;284(1):575-584 PubMed

J Bone Miner Res. 2005 Nov;20(11):1901-4 PubMed

Clin Chem Lab Med. 2011 Nov 14;50(2):333-5 PubMed

Osteoporos Int. 2013 May;24(5):1751-7 PubMed

Best Pract Res Clin Rheumatol. 2008 Mar;22(1):129-48 PubMed

Osteoporos Int. 2010 Apr;21(4):667-77 PubMed

J Bone Miner Res. 2013 May;28(5):1170-9 PubMed

Calcif Tissue Int. 2013 Jan;92(1):15-22 PubMed

Bone. 2001 Apr;28(4):446-53 PubMed

Rheumatol Int. 2010 Aug;30(10):1341-8 PubMed

J Bone Miner Res. 2009 Aug;24(8):1358-68 PubMed

Calcif Tissue Int. 2012 Sep;91(3):186-95 PubMed

Osteoporos Int. 2008 Sep;19(9):1331-41 PubMed

Acta Biomater. 2010 Dec;6(12):4513-21 PubMed

Bone. 2002 Jul;31(1):107-9 PubMed

J Bone Miner Res. 2010 Aug;25(8):1886-94 PubMed

Bone. 2009 Aug;45(2):200-6 PubMed